Difference between revisions of "TC99m Biomarker Committee"
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
==Recent Meetings/Call Summaries== | ==Recent Meetings/Call Summaries== | ||
| + | *[[Media:2019_01-15_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | January 15, 2019]] | ||
*[[Media:2018_11-13_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | November 13, 2018]] | *[[Media:2018_11-13_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | November 13, 2018]] | ||
*[[Media:2018_10-09_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | October 9, 2018]] | *[[Media:2018_10-09_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | October 9, 2018]] | ||
Revision as of 21:26, 12 February 2019
- Co-chairs: Yuni Dewaraja, PhD; Robert Miyaoka, PhD
- Secretary: Julie Lisiecki
Full name of biomarker committee: Technetium-99m for body, oncology, and immunology